Sansone, S.; Amir, Y.; Lebwohl, M. Safe Use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients With a History of Lymphoproliferative Disease. J of Skin 2020, 4, 256-259.